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Available online 26 May 2012Ataxia Telangiectasia Mutated (ATM) protein kinase is a key effector in the modulation of
the functionality of some important stress responses, including DNA damage and oxidative
stress response, and its deficiency is the hallmark of Ataxia Telangiectasia (A-T), a rare
genetic disorder. ATM modulates the activity of hundreds of target proteins, essential for
the correct balance between proliferation and cell death. The aim of this study is to evaluate
the phenotypic adaptation at the protein level both in basal condition and in presence of
proteasome blockage in order to identify the molecules whose level and stability are
modulated through ATM expression. We pursued a comparative analysis of ATM deficient
and proficient lymphoblastoid cells by label-free shotgun proteomic experiments compar-
ing the panel of proteins differentially expressed. Through a non-supervised comparative
bioinformatic analysis these data provided an insight on the functional role of ATM
deficiency in cellular carbohydrate metabolism's regulation. This hypothesis has been
demonstrated by targeted metabolic fingerprint analysis SRM (Selected Reaction Monitor-
ing) on specific thermodynamic checkpoints of glycolysis. This article is part of a Special
Issue entitled: Translational Proteomics.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.Keywords:
ATM kinase
Proteasome
Shotgun
Carbohydrate metabolism1. Introduction
Ataxia Telangiectasia (A-T) is an autosomal recessive disorder.
The clinical hallmark of the disease is progressive neuromotor
dysfunction resulting from gradual cerebellar cortical atrophy
and Purkinje cells degeneration. Additional important features
are telangiectasia in the eyes, thymic degeneration, immuneled: Translational Proteom
tabonomic Laboratory, F
3332.
.it (A. Urbani).
 CC BY-NC-ND license.deficiency, premature aging and higher predisposition to
develop lymphomas and leukemia [1,2]. Moreover, A-T patients
are highly sensitive to ionizing radiations (IR) [3]. A-T is linked to
mutations of the ATM (Ataxia Telangiectasia Mutated) gene on
both alleles, which ultimately impair the production of a
functional ATM protein [4,5], a serine/threonine-PI3-kinase
like protein originally identified as a central player of the DNAics.
ondazione Santa Lucia, Via del Fosso di Fiorano 64, 00143 Rome,
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its function through the phosphorylation of several protein
substrates. These include proteins involved in cell cycle control,
DNA repair and apoptosis, such as p53, Chk2, MRN complex,
Rad51 and many more [3]. Following DNA damage, ATM
molecule is (auto)phosphorylated on Ser 1981 and phosphory-
lation on this site has been proposed as a signature of an
activation event [6]. ATM is activated mainly by DNA double
strand breaks (DSBs), a cytotoxic lesion induced by IR, radiomi-
metic agents, such as neocarzinostatin (NCS), reactive oxygen
species accompanying normal metabolism, and it triggers cell
cycle arrest andDNA repair aswell as, depending on the cellular
context and on the severity of the damage, programmed cell
death or apoptosis [7]. Increasing evidence suggests that the
ubiquitin system plays a crucial role in the DDR providing a
timed and coordinated degradation or relocalization or activa-
tion of regulatory proteins essential for the execution of the
DDR [8]. In fact, cellular homeostasismaintenance and ability of
adaptation to the environment depend on degradation of
regulatory proteins. Furthermore, more recently non‐degrada-
tive ubiquitylation of DNA repair proteins has been shown to
play an essential role in the DDR. This post-translational
modification of key DDRmolecules provides direct and indirect
routes to damage site recognition for DNA repair proteins [9].
Phosphorylation-dependent or independent ubiquitylation and
deubiquitylation affect protein localization and pathway acti-
vation/inactivation and are signals regulating the multiple
mechanisms allowing for DDR transient activity [10].
The ubiquitin–proteasome (Ub–P) system plays a key role in
maintaining the integrity of cellular proteome and in protecting
cells from protein damage. Accumulation of damaged proteins
can interfere with normal cellular processes and may directly
induce cell death. Under normal circumstances, ubiquitylation of
proteins acts as a quality control mechanism, marking and
destroying improperly manufactured proteins. Indeed upon
cellular stresses such as metal and oxidants exposure or heat
shock, there is a significant increase of ubiquitylated proteins
level in the cell, and aberrations in this pathway are implicated in
the pathogenesis of several diseases, including many neurode-
generative disorders [11,12].
In this scenario, it has been demonstrated that Ub–P is also
induced in response to ATM kinase activation. NCS treatment
endogenously increases ubiquitin conjugates in lymphoblastoid
cells. A-T cells show an attenuated ability to mount the
ubiquitylation response to stress, supporting a role of ATM in
modulating the ubiquitylation machinery [13]. ATM modulates
the activity of E3ubiquitin ligases, affecting indirectly the stability
of target proteins: for example the E3 ubiquitin ligasesMDM2 and
COP1 have been identified as ATM substrates and their ATM-
dependent phosphorylation results in the inhibition of their
enzymatic activitywhich in turn triggers p53 stabilization [14–16].
Recently, Stagni and colleagues have shown that ATMmodulates
the proteasome dependent down-regulation of c-FLIP therefore
affecting death receptor induced apoptosis [17,18]. Furthermore it
has been shown that ATM activity triggers NEMO ubiquitylation
and NF-κB activation modulating the TNFα response [19]. A
recent paper demonstrates how protein proteasome-mediated
degradation is negatively affected in A-T cells due to the ATM
impairment of ISG15 (an ubiquitin-like protein) pathway [20].
Importantly, proteomic approaches aimed to deciphering ATMsubstrates identified more than 700 proteins as novel ATM
targets among which the Ub–P system is highly represented
[21–23]. Moreover, these studies suggested that ATM may
importantly contribute to several cellular functions beside
DNA damage response. Indeed, DDR independent roles of
ATM as cytoplasmic protein involved in different biochemical
phenomena are starting to emerge linking ATM deficiency to
increased oxidative stress, neurodegeneration, metabolic dys-
regulation and oncogenesis (reviewed in [24]). ATM participates
in maintenance of cellular redox homeostasis by up-regulation
of antioxidants, increasing production of reductive precursors
and decreasing reactive oxygen species (ROS) production by
mitochondria. Accordingly, the absence of a functional ATM
results in a continuous state of oxidative stress causing adverse
effects on particularly sensitive cells as neurons [25,26].
Moreover, an intrinsic up-regulation of ROS and mitochon-
dria dysfunction are exhibited by ATM deficient lymphoblas-
toid cells [27] and Cheema and colleagues reported that ATM
controls oxidative stress by regulating purine, pyrimidine
and urea cycle pathways [28]. Interestingly, H2O2 dependent
ATM Cys-2991 dimer formation was proposed as oxidation
activation mechanism different from the classic Ser-1981
autophosphorylation occurring after the DBSs [29]. Other
evidences supported ATM role in regulation of metabolic
signaling pathways. ATM participates in insulin signaling
through phosphorylation of eIF-4E-binding protein 1 [30] and
glucose metabolism is affected by ATM activity as the levels
of Insulin-like growth factor 1 receptor (IGFR1) are reduced in
ATM-deficient cells [31] and translocation of the cell-surface
Glucose transporter 4 (GLUT4) is regulated indirectly by ATM in
response to insulin stimulation [32]. Moreover, a link between
ATMand thepentose phosphate pathwayhas beenprovided [33]
and ATM activity modulates metabolic syndrome [34,35].
Overall, these data confirm that ATM deficiency affects the
cellular proteome composition resulting in multiple defective
signaling pathways. Therefore, we developed a non-targeted
proteomic investigation to analyze the profile of proteins whose
levels change in response toATMexpression in order to elucidate
the role of ATM in the control of protein quality and stability. To
this aim, protein expression profiling was also assessed in the
presence of the proteasome inhibitor MG132 to highlight those
proteins whose expression is modulated by ATM most likely
through theubiquitin–proteasome system.Our investigationwas
pursued by the use of isotope-free shotgun proteomics approach
that provides a relatively high-throughput assessment of
changes in protein expression, which may act as a molecular
remnant of ATM activitymechanism, and generates raw data for
unsupervised data-mining of functional biological process. This
approach allowed us to obtain an overview on the role of ATM in
the modulation of the proteome, thereby offering a better
understanding of its physiologic and pathologic implication.2. Materials and methods
2.1. Cell lines, antibodies and reagents
L6pCDNA (L6), L6-Flag-ATM-wt (L6ATM), GM-03189 and HeLa
cell lines were cultured as described previously [17,18,36].
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mAb was purchased from ENZO Life Sciences (Farmingdale,
NY, USA). Anti-ATM (clone 2C1) mAb, anti-Lamin B (M-20) Ab,
anti Matrin-3 (C-20) Ab, anti PGAM1 (6) mAb, anti-PGK1 (Y-12)
Ab, anti PKM2 (H-59) Ab, anti-Stat1 (M-22) Ab and anti-T-
Plastin (A-3)mAbwere obtained fromSantaCruz Biotechnology
(Santa Cruz, CA, USA). Anti-hnRNP F+H (1G11) mAb was
obtained by Abcam (Cambridge, UK) and anti-GLRX1 (AF3119)
Ab from R&D Systems Inc. (Minneapolis, MN, USA). Anti-β-
Actin (cloneAC-15)mAbandanti-α-Tubulin (CloneDM1A)mAb
were purchased from Sigma-Aldrich (Saint Louis, Missouri,
USA). ShATM construct and its control (shSc) were described
elsewhere [18]. The proteasome inhibitor Z-Leu–Leu–Leu-al
(MG132), DMSO, Trizma base, Urea, CHAPS, Iodoacetamide
(IAA), DTT, [Glu1]-Fibrinopeptide B, Ammonium acetate, Meth-
anol, Ethanol, Acetone and standard compounds (glucose 6–
phosphate, fructose 1,6-bisphosphate, glyceraldehyde 3–phos-
phate, pyruvate, lactate) were purchased from Sigma. Sequence
grade trypsinwas purchased fromPromega (Madison,WI, USA).
Water ultra-gradient, Acetonitrile ultra-gradient (ACN), TFAand
Formic Acid (FA) were purchased by Romil (Cambridge, UK).
2.2. Immunoblotting
Protein extracts were obtained by lysing and sonicating cells
in 6 M Urea, 100mM Tris pH 7.5 and 0.5% CHAPS. Protein
concentration was determined by the Bio-Rad Protein Assay
(Bio-Rad Laboratories, Hercules, CA, USA). Equal amounts of
proteins were resolved by 1-D-SDS-PAGE and blotted onto
nitrocellulose membranes using a Hoefer SemiPhor semidry
transfer unit (Amersham Biosciences, Uppsala, Sweden). Blots
were incubated with the indicated primary antibodies, exten-
sively washed and, after incubation with horseradish peroxidase
(HRP)-labeled goat anti-mouse or anti-rabbit (Bio-Rad Laborato-
ries) or bovine anti-goat Ab (Santa Cruz), developed with the ECL
plus chemiluminescence's detection system (GE Healthcare, UK).
The band intensities were quantified and normalized with those
ofα-Tubulinusing the imageanalysis software: ImageQuant™TL
(GE Healthcare). Three independent experiments were done for
each detected protein.
2.3. Expression analysis by nLC-MSE
Proteins extracted from 10×106 L6 and L6ATM cells, treated
with 10 μM MG132 or 1:1000 DMSO (control) for 2 hours, were
quantified by Bio-Rad assay. Three different experiments were
performed and four protein pools were obtained (L6, L6MG132,
L6ATM and L6ATMMG132), collecting 50 μg of protein from each
experiment. Proteins poolswere precipitated adding a coldmix of
Ethanol, Methanol and Acetone (ratio 2:1:1, v/v), and redissolved
in 6 MUrea, 100mMTris pH 7.5. After reductionwith 10mMDTT
and alkylation with 20mM IAA, protein samples were digested
100:1 (w/w) with sequence grade trypsin at 37 °C overnight. The
reactionwas stoppedby adding a final concentrationof 0.1%TFA.
Sampleswere dilutedwith 0.1% FA, 3%ACN at a concentration of
0.86 μg/μl, and 1.72 μg of proteindigestionwere loadedon column
for peptide separation. Prior of loading, 100 fmol/μl Saccharomyces
cerevisiae Enolase digestion (Waters,Milford, MA, USA)was added
to samples as internal standard. Peptideswere trapped on a 5 μmSymmetry C18 trapping column 180 μm×20mm (Waters) and
separated using a 180min RP gradient at 300 nl/min (3 to 40%
ACN over 125min) on a nanoACQUITY UPLC System (Waters),
utilizing a 1.7 μmBEH130C18NanoEase 75 μm×25 cmnanoscale
LC column (Waters). The lock mass ([Glu1]-Fibrinopeptide B, 500
fmol/μl) was delivered from the auxiliary pump of the UPLC
System with a constant flow rate of 250 nl/min. The separated
peptides weremass analyzed by a hybrid quadrupole orthogonal
acceleration time-of-flight mass spectrometer (Q-Tof Premier,
Waters Corp., Manchester, UK) directly coupled to the chromato-
graphic system and programmed to step between low (4 eV) and
high (15–40 eV) collision energies on the gas cell, using a scan
time of 1.5 s per function over 50–1990 m/z (Expression analysis
[37,38]). Three continuum LC-MS data for each pool were
processed for qualitative and quantitative analysis using the
software ProteinLynx Global Server (version 2.4, PLGS, Waters).
Protein identifications were obtained with the embedded ion
accounting algorithm of the software and searching a human
database (UniProtKB/Swiss-Prot Protein Knowledgebase, release
2011_06 of 31-May-11 containing 529056 sequence entries;
taxonomical restrictions: Homo sapiens, 20235 sequence entries)
to which data from S. cerevisiae Enolase was appended. The
search parameters were automatic tolerance for precursor ions
and for product ions, minimum 3 fragment ions matched per
peptide, minimum 7 fragment ions matched per protein,
minimum 2 peptide matched per protein, 1 missed cleavage,
carbamydomethylation of cysteine as fixed modification and
oxidation of methionine as variable modification. The false
positive rate estimated was under 4%, as previously described
[39]. Quantitative analyses have been performed by data inde-
pendent alternate scanning expression algorithm. Identified
proteins were normalized against P00924 entry (S. cerevisiae
Enolase) while the most reproducible peptides for retention
timeand intensity deriving fromEnolasedigestion (756.4604m/z,
807.4302 m/z, 814.4923 m/z, 1159.6069 m/z, 1159.6069 m/z,
1755.9429 m/z) were used to normalize the EMRTs table, that is
the list of peptide (ExactMasses paired to their Retention Times).
In fact, the processing of the two mass spectrometric data
functions, low energy and elevated energy, plus data of the
reference lock mass, provides a time-aligned inventory of
accurate mass-retention time components for both the low and
elevated-energy (EMRT). The entire differentially expressed
proteins data set was filtered by considering only those identifi-
cations from the alternate scanning LC-MSE data with identified
peptides exhibiting good replication rate (at least two out of three
injections) and with a probability of upregulation (p-value) lower
than 0.05 and upper than 0.95 associated to the relative protein
fold change. Furthermore, the significance of regulation levelwas
determined at 30% fold change, that is an average relative fold
change between −0.30 and 0.30 on a natural log scale, which is
typically 2–3 times higher than the estimated error on the
intensity measurement (for more details see Supplementary
Information Data S1).
2.4. Bioinformatic analysis
To identify Gene Ontology (GO) classes and biologically relevant
molecular pathways fromour large-scale datawe have analyzed
the proteomics dataset by using two different bioinformatic
analysis tools endowed with a comprehensive knowledgebase,
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(PANTHER) Classification System (version 7.0 http://www.
pantherdb.org) [40] and Ingenuity Pathways Analysis (IPA;
version 9.0, Ingenuity Systems, http://www.ingenuity.com). By
PANTHER resource genes products can be categorized by their
molecular functions and/or biological processes on the basis of
published papers and by evolutionary relationships to predict
function when interpreting experimental evidence is challeng-
ing. Ingenuity PathwaysAnalysis is aweb-based application that
enables mining, visualization and exploration of relevant
functional associations significant to the experimental results.
The analysis settings applied were: Reference set: Ingenuity
Knowledge Base (Genes Only); Relationship to include: Direct
and Indirect; Includes Endogenous Chemicals; Filter Summary:
Consider all molecules and/or relationships. The most signifi-
cant categories associated to the uploaded datasets were
identified by calculating the related significance (p-value)
statistically evaluated by the Fischer's exact test. The p-value
measures the likelihood that the association between the genes/
proteins in the datasets and each Canonical Pathway, Biological
Function, etc., is not due to random chance alone identifying
significant over-representation of molecules in association to a
given process. We applied a p-value threshold of 0.05, limiting
the false discovery rate (i.e., the expected fraction of false
positives among significant functions) to less than 5%.
2.5. Metabolomics analysis
100 μL of a mixture of ethanol/water 80:20 were added to
20×106 cell pellets. Cells were sonicated for 20 min and then
samples were centrifuged (25,000g, 4 °C, 20 min). Superna-
tants were analyzed by an LC-MS/MS system consisting of a
Waters Alliance HT 2795 HPLC SeparationModule coupled to a
Waters Quattro Ultima Pt ESI tandem quadrupole mass
spectrometer (Waters). The instrument was operated in nega-
tive electrospray ionizationmodeusingMassLynx v. 4.0 software
(Waters) and data processing was performed using QuanLynx
software (Waters). For HPLC analysis, the Atlantis HILIC Silica
3 μm 2.1×150mm column (Waters) was used. 25 μl of the
extracted samples were injected onto the HPLC-MS/MS system.
The mobile phase comprised a binary solvent system: ACN
(solvent A) and water containing 50mmol/l Ammonium acetate
(solvent B). The initial solvent composition was 100% A. 100%A
wasmaintained for 3 min; decreasing from the initial conditions
to 50%Awithin 8.0 min, holding for 4 min before returning to the
initial state at 12.0 min, allowing 4 min for column re-
equilibration. The total run time was 16 min, injection-to-
injection. The flow ratewas 0.3 ml/min. Themass spectrometer
ionization source settings were optimized formaximumprecur-
sor ion yields for eachmetabolite. This was achieved by infusing
a 1 μg/mlmethanolic solution of each individual compound. The
following transitions were monitored for the metabolites of
interest: glucose 6–phosphate (G 6–P) 258.80>96.80, cone 40 V
and collision energy 13 eV; fructose 1,6–bisphosphate (F 1,6–P)
338.90>96.90, cone 40 V and collision energy 15 eV; glyceralde-
hyde 3–phosphate (G 3–P) 168.80>96.90, cone 40 V and collision
energy 5 eV; pyruvate (P) 86.90>43.10, cone 40 V and collision
energy 5 eV; lactate (L) 88.90>43.10, cone 40 V and collision
energy 6 eV. The capillary voltage was 3.00 kV, source temper-
ature was 100 °C, desolvation temperature was 400 °C, and thecollision cell gas pressure was 3.5×10−3 mbar argon. The inter-
channel and inter-scan delay times were 0.02 and 0.10 s,
respectively. The dwell time was 0.200 s for each analyte.3. Results
3.1. Shotgun proteome profiling by label-free nUPLC-MSE
We pursued a proteomic investigation to analyze the profile of
proteins whose levels change in response to ATM expression
in order to elucidate the role of ATM in the control of protein
quality and stability. In the attempt to investigate the different
protein profiling in presence of absence of ATMwe focalized our
study on two cell lines previously established [17]: lymphoblas-
toid ATM deficient cells from an A-T patient stably transfected
with constructs that allow the expression of either FLAG-ATM-
wt protein (L6-ATM-wt=L6ATM) or the empty vector as control
(L6-pCDNA=L6). These two cell lines were obtained from the
same lymphoblastoid clone; consequently they have the same
genetic background and are specifically different only for the
reconstitution of ATM expression. Therefore, the differences
observed comparing these cell lines are reasonably, mainly due
to the different expression of ATM protein. L6 and L6ATM cells
were incubated 2 hours in the presence or in the absence of the
proteasome inhibitor MG132 10 μM (Fig. 1). Two different
datasets were analyzed: on the one hand a comparison between
the proteome of L6ATM cell line and L6 cells (L6ATM vs L6); on
the other hand a parallel betweenMG132 treated L6ATMcell line
andMG132 treated L6 cells (L6ATMMG132 vs L6MG132). The first
dataset allowed us to investigate the differences in proteome
composition only due to the presence/absence of ATM. The
treatment with MG132 [41] allowed to highlight those proteins
whose half-life is particularly short and their ATM dependent
modulation levels over the whole proteome would be partially
masked in a direct investigation. The comparative proteome
analysis was performed by nano ultra performance liquid
chromatography (nUPLC) coupled to MSE isotope free shotgun
profiling. Using this approach, we identified a total of 123153
molecular spectral features (EMRTs) and 473 proteins across
both conditions of the first dataset (L6ATM vs L6); 119759 EMRTs
and 503 proteins in the second dataset (L6ATM MG132 vs L6
MG132). Quality control measures were performed on the
replicates to determine the mass measurement and the
chromatographic retention time analytical reproducibility
of each peptide (Fig. S1). The subsequent strategy for quantify-
ing proteome profile data for differential expression analysis
relies on changes in the peptide analyte signal response from
each EMRT component that directly reflect their concentrations
in one sample relative to another. Applying this experimental
approach the label-free shotgun analysis of the two cell lines
revealed that L6ATM cells showed significantly different levels
of 53 proteins compared to L6 (Tables 1, S1–S7). The proteomic
analysis of the second dataset under study (MG132 treated
L6ATM vsMG132 treated L6 cells) led us to identify 62 proteins
differentially expressed (Tables 2, S1, S8-S13). Among these
identified proteins 12 were present in both comparison
condition (see Tables 1 and 2).
Fig. 1 – Assessment of proteasome inhibition. L6 and L6ATM
cells treated 2 hours with 10 μM MG132 or DMSO 1:1000
(control). For immunoblotting, 50 μg protein extract were
separated by SDS-PAGE and transferred on nitrocellulose.
(A) Proteasome inhibition were confirmed by anti-Mono- and
polyubiquitinylated conjugates (clone FK2) antibody. (B) ATM
expression were assessed by anti-ATM western blot.
(C) Equal protein loading was confirmed by β-Actin
expression.
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Bioinformatics analysis was performed in order to analyze the
functions of co-expressed genes and gain insight into the
stressed process related to the absence of ATM activity. High-
throughput experimental techniques, such as label-free prote-
omics analysis, produce large amounts of data but these data
are of little use if it is not possible to interpret the results in a
biological context. Therefore, we have analyzed our proteomics
dataset by using two bioinformatic analysis tools, such as
Protein Analysis Through Evolutionary Relationships (PAN-
THER) classification system and Ingenuity Pathways Analysis
(IPA). Using the PANTHER resource we classified biologically
relevant functional annotations of the differentially expressed
polypeptides. The proteins identified in the two dataset of
L6ATM vs L6 and L6ATMMG132 vs L6MG132were examined for
their knownGObiological process and grouped in the respective
functional category. The most represented biological process
(with 25% and 21% respectively) was linked to cellular metab-
olism (Fig. 2). To gain deeper insight into the plausible cellular
andmolecular networks in which the identified proteins mightbe involved, we used the two experimental dataset of L6ATM vs
L6 and L6ATM MG132 vs L6 MG132 regulated dependent gene
products to query IPA. In fact, Ingenuity Pathway Core Analysis
reveals assessment of the enriched signaling and metabolic
pathways, molecular networks, and biological processes that
are most significantly perturbed in the dataset of interest. This
unbiased systems biology approach identified significant over-
representation of proteins involved in Glycolysis/gluconeogen-
esis canonical pathway for both comparison, respectively p-
value=3.34E−07 and p-value=6.68E−07. These results are based
on the ATM dependent differentially expression of some
glycolytic/gluconeogenetic enzymes: Enolase 2 (gamma, neuro-
nal), Glyceraldehyde-3–phosphate dehydrogenase, Glucose-6–
phosphate isomerase, Phosphoglycerate mutase 1 (brain)
(PGAM1), Phosphoglycerate kinase 1 (PGK1), Pyruvate kinase
isozymes M1 M2 (PKM2). Moreover, in both dataset (L6ATM vs L6
and L6ATMMG132 vs L6MG132) among the top affectedMolecular
and Cellular Functions is the Carbohydrate Metabolism (p-value
calculated for the first dataset: 7.11E−08 to 2.15E−02; for the second
one: 6.34E−06 to 4.43E−02) (Tables 3 and S14).
3.3. Protein expression and pathway analysis validation
To validate our results, we selected one sub-set of proteins
among those identified as differentially expressed by label-
free shotgun experiments and checked their expression by
means of western blot analysis performed on new cellular
extracts (Fig. 3). The choice was made on the basis of the
pathway analysis (selecting three enzyme: PGK1, PKM2 and
PGAM1) and literature available information coherent with
already published paper and/or with known ATM function
(selecting other six proteins: hnRNPH, GLRX1, Plastin3, STAT1,
LaminB and Matrin3. For detailed literature references see
subsequent Result and Discussion section). Interestingly, we
confirmed several data from other proteomic based studies
(Table S15) [21–23,28,42] related to ATM and performed on
other cell lines. A-T cells have a high level of genome instability,
and therewere likely numerous genetic changes before thewild
type ATM protein was added back. The consistency of our
experimental with those obtained by other cell lines enforced
the collected results. . Moreover, in addition of both the L6 cell
lines, we performed the western blot validation on two other
cell lines, characterized by distinct genetic background: GM-
03189 (lymphoblastoid cell line derived from an A-T patient)
and a stable interfered for ATM HeLa cell line plus the relative
control. All the proteins we analyzed both through proteomic
and western blot analysis exhibited the same trend in up- or
down-regulation of protein expression except for Matrin 3
(Fig. 3E, F). From proteomic analysis we noticed a high
increment of Matrin 3 protein levels in L6 ATM treated with
MG132; on the contrary protein levels analyzed by western blot
seem to be lower. This contradictory result highlights again a
well-known technical issue on differences between the two
different types of experimental methods we adopted (nLC-MS/
MS and western blot analysis); we could explain this discrep-
ancy pondering over the inherent errors and limits of each
technique and on the quality of commercial antibodies. More-
over, the down-regulation of Plastin 3 in absence of ATM was
confirmed bymeans of western blotting in the L6 cells but not in
Table 1 – Significant differentially regulated proteins in L6ATM and L6 cells comparison identified by label-free LC-MSE.
Accessiona Description (GN=gene name) Scoreb Highly
representedc
L6ATM:
L6
Ratio
L6ATM:
L6
Log(e)
Ratio
L6ATM:L6
Log(e)
StdDev
P14174 Macrophage migration inhibitory factor GN=MIF 7075.59 L6ATM
P53999 Activated RNA polymerase II transcriptional coactivator p15
GN=SUB1
2139.7 L6ATM
Q32P51 Heterogeneous nuclear ribonucleoprotein A1 like 2
GN=HNRNPA1L2
1504.35 L6ATM
P01876 Ig alpha 1 chain C region GN=IGHA1 1479.68 L6ATM
P39687 Acidic leucine rich nuclear phosphoprotein 32 family member
A GN=ANP32A
1443.88 L6ATM
P35268 60 S ribosomal protein L22 GN=RPL22 681.5 L6ATM
O14979 Heterogeneous nuclear ribonucleoprotein D like GN=HNRPDL 633.7 L6ATM
P55795 Heterogeneous nuclear ribonucleoprotein H2 GN=HNRNPH2 445.99 L6ATM
O60812 Heterogeneous nuclear ribonucleoprotein C like 1
GN=HNRNPCL1
413.2 L6ATM
Q15181 Inorganic pyrophosphatase GN=PPA1 376.52 L6ATM
P07954 Fumarate hydratase mitochondrial GN=FH 325.39 L6ATM
Q16658 Fascin GN=FSCN1 319.98 L6ATM
P12956 X ray repair cross complementing protein 6 GN=XRCC6 256.08 L6ATM
A6NHL2 Tubulin alpha chain like 3 GN=TUBAL3 173.35 L6ATM
P17844 Probable ATP dependent RNA helicase DDX5 GN=DDX5 147.85 L6ATM
P52272 Heterogeneous nuclear ribonucleoprotein M GN=HNRNPM 129.17 L6ATM
Q9Y4L1 Hypoxia up regulated protein 1 GN=HYOU1 115.98 L6ATM
P46940 Ras GTPase activating like protein IQGAP1 GN=IQGAP1 112.27 L6ATM
P13797 Plastin 3 GN=PLS3 473.76 7.03 1.95 0.38
Q99867 Putative tubulin beta 4q chain GN=TUBB4Q 787.96 4.44 1.49 0.2
P06454 Prothymosin alpha GN=PTMA 8347.55 2.36 0.86 0.09
Q15233 Non POU domain containing octamer binding protein
GN=NONO
467.49 2.14 0.76 0.13
P07910 Heterogeneous nuclear ribonucleoproteins C1 C2 GN=HNRNPC 934.28 1.8 0.59 0.08
P00558 Phosphoglycerate kinase 1 GN=PGK1 546.96 1.73 0.55 0.05
P31947 14 3 3 protein sigma GN=SFN 751.6 1.67 0.51 0.51
P14618 Pyruvate kinase isozymes M1 M2 GN=PKM2 3573.08 1.58 0.46 0.03
P31943 Heterogeneous nuclear ribonucleoprotein H GN=HNRNPH1 251.07 1.48 0.39 0.1
P30101 Protein disulfide isomerase A3 GN=PDIA3 306.45 1.48 0.39 0.07
P19338 Nucleolin GN=NCL 323.14 1.45 0.37 0.08
P04406 Glyceraldehyde 3 phosphate dehydrogenase GN=GAPDH 21300.61 1.39 0.33 0.03
P18669 Phosphoglycerate mutase 1 GN=PGAM1 3870.24 1.35 0.3 0.06
P27348 14 3 3 protein theta GN=YWHAQ 2381.94 0.73 −0.32 0.17
Q13509 Tubulin beta 3 chain GN=TUBB3 5054.55 0.72 −0.33 0.16
P54652 Heat shock related 70 kDa protein 2 GN=HSPA2 1879.25 0.72 −0.33 0.25
P13929 Beta enolase GN=ENO3 1278.2 0.71 −0.34 0.3
P31146 Coronin 1A GN=CORO1A 4864.42 0.66 −0.42 0.05
P14866 Heterogeneous nuclear ribonucleoprotein L GN=HNRNPL 373.99 0.64 −0.45 0.13
P35579 Myosin 9 GN=MYH9 484.58 0.63 −0.47 0.05
Q562R1 Beta actin like protein 2 GN=ACTBL2 5361.02 0.59 −0.53 0.04
P08107 Heat shock 70 kDa protein 1A 1B GN=HSPA1A 813.92 0.48 −0.73 0.23
Q14974 Importin subunit beta 1 GN=KPNB1 636.75 0.4 −0.91 0.12
Q9Y281 Cofilin 2 GN=CFL2 5716.25 0.36 −1.01 0.26
Q6ZMR3 L lactate dehydrogenase A like 6A GN=LDHAL6A 446.94 0.26 −1.36 0.58
Q04917 14 3 3 protein eta GN=YWHAH 802.25 0.24 −1.43 0.21
P34931 Heat shock 70 kDa protein 1 like GN=HSPA1L 840.22 0.11 −2.22 0.35
P26641 Elongation factor 1 gamma GN=EEF1G 255.88 L6
P20591 Interferon induced GTP binding protein Mx1 GN=MX1 265.5 L6
P07602 Proactivator polypeptide GN=PSAP 331.8 L6
P61158 Actin related protein 3 GN=ACTR3 425.19 L6
P23381 Tryptophanyl tRNA synthetase cytoplasmic GN=WARS 690.49 L6
P35754 Glutaredoxin 1 GN=GLRX 1109.59 L6
P13284 Gamma interferon inducible lysosomal thiol reductase
GN=IFI30
1124.13 L6
P09211 Glutathione S transferase P GN=GSTP1 3276.57 L6
(continued on next page)
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background and phenotypic adaptation among the two lympho-
blastoid cell lines.
Western blot validation of the overexpression of three
proteins belonging to the glycolysis pathway (PGK1, PGAM1
and PKM2, see Fig. 3A, B) and the interesting bioinformatics
outcome strongly supports the idea that there is a modulation
of the glycolytic metabolism in absence of ATM activity. To
better qualify this potential metabolic shunt we decided to
assess the related metabolic changes by HPLC-MS/MS analy-
sis. In fact, it is not possible only with the performed
bioinformatics analysis (GO protein annotation inferred by
PANTHER and enrichment function and pathway analysis by
IPA) to qualify if the identified process are down-regulated or
up-regulated between samples; both bioinformatics tools are
based only on the experimental proteins number (and not on
their up- or down-regulation) under study by comparing the
annotation terms outcome to the reference background (whole
annotated functions). Five metabolites were evaluate monitor-
ing their mass spectrometry transitions: glucose 6–phosphate
(G 6–P), fructose 1,6–bisphosphate (F 1,6–P), glyceraldehyde 3–
phosphate (G 3–P), pyruvate (P) and lactate (L) (Fig. 4). Levels of G
6–P, F 1,6–P and G 3–P intermediate glycolytic metabolites were
higher in absence of ATM. On the contrary, levels of the end
products of glycolysis (pyruvate) (approximately 1.5-fold in-
crease), and lactate (approximately 3-fold increase) were higher
in agreement with the higher expression level of PKM2 in ATM
reconstituted L6 comparedwith the native L6ATMdeficient cell
line. PKM2 is the rate-limiting enzyme of the glycolysis and
catalyzes the transphosphorylation fromphosphoenolpyruvate
(PEP) to ADP as the last step of glycolysis to generate ATP and
pyruvate. Hu et al. described an up-regulation of Pyruvate
kinase isozymes M1 M2 (PKM2) in ATCL8 cells (expressing a
functional ATM) compared with AT5BIVA (fibroblast cell line
derived from a patient with A-T) due to 3 hours of irradiation
[42]. Moreover, in another of proteomic study previously
indicated, the authors isolated PKM2 through a large-scale
proteomic analysis of proteins phosphorylated in response to
DNA damage on consensus sites recognized by ATM and ATR
[23]. Intriguingly is known in literature a nuclear translocation
of PKM2 in response to different apoptotic stimuli and this
nuclear translocation is sufficient to induce programmed cell
death [43]. Our results and the reported published evidences
confirm the hypothesis that PKM2 could be considered as one of
the ATM target protein. Nevertheless, we observed an up-
regulation of PKM2 in L6 ATM reconstituted cell line only in
basal condition and not after the MG132 treatment. We can
hypothesize that in the absence of ATM this protein is more
degraded by the Ub-proteasome system and after the protea-
some blockage there is an accumulation of the ubiquitylatedNotes to Table 1:
a: Unique protein sequence identifier according to UniProtKB/Swiss-Prot
b: ProteinLynx Global Server score.
c: Protein found highly represented in L6ATM or in L6 cells (ratio >20 or <
d: Ratio of expression between L6ATM and L6.
Boldface type indicates proteins identified as differentially regulated and w
Proteins confirmed by way of western blotting are underlined.
Details of proteins and peptides identification are reported in Supportingprotein in both cell line explaining the absence of different
expression between the two treated cell lines in our study.
The last monitored metabolite, lactate, was found more
concentrated in presence of ATM (approximately 3-fold increase
in basal condition and 2-fold increase after MG132 treatment,
Fig. 4) according to the higher amount of its precursor pyruvate.
Normally, lactate is produced inmammalianorganismwhen the
oxygen availability is decreased in a reduction reaction that
produces NAD+ from NADH and H+. In our cellular system we
hypothesize that the lactate higher amount depends on its
functions as thermodynamic driving force to push the glycolytic
step of the Glyceraldehyde 3 phosphate dehydrogenase (GAPDH)
which is enzymatically acting in near equilibrium condition.4. Discussion
Ataxia Telangiectasia (A-T) is a genetic disease characterized
by cerebellar ataxia and immunodeficiency. A-T is linked to
the loss of ATM protein function, a serine/threonine kinase
central in DNA damage response. ATM modulates also the
activity of E3-ubiquitin-ligases, affecting the stability of target
proteins. Therefore, ATM deficiency may severely impinge on
the cellular proteome composition resulting in defective signal-
ing pathways. In fact, there are increasing evidence that this
protein may have an important role in the control of target
proteins of the ubiquitin system. Stagni and colleagues have
recently shown that ATMmodulates the proteasome dependent
down-regulation of c-FLIP [17,18]. In the present study, we have
pursued a comprehensive proteomic investigation to evaluate
the biological effects of ATM expression on the control of protein
quality and stability. To this aim, protein expression profiling
were also assessed in the presence of the proteasome inhibitor
MG132 to highlight those proteins whose expression is modu-
lated by ATM most likely through the ubiquitin–proteasome
system and whose half-life is particularly short and their ATM
dependentmodulation levels over thewhole proteomewould be
partially masked in a direct investigation. By label-free nLC-MSE
approach, a total of 53 and 62 differentially expressed proteins
were identified in the two analyzed comparison (L6ATM vs
L6ATM andMG132 treated L6ATM vsMG132 treated L6 cell lines,
respectively). Twelve proteins are regulated in the same way in
both experimental dataset and we can speculate that their
expression is influenced by the presence/absence of ATM but
this event occurs independently of the ubiquitin–proteasome
system involvement. Remarkably one of them, Plastin 3 (PLS3),
differentially regulated in both dataset of the shotgun proteomic
experiments (overepressed in L6ATM cell line in presence or
absence ofMG132, Tables 1 and 2, Fig. 3A, B), is already known as
phosphorylated upon DNA damage, probably by ATM or ATRProtein Knowledgebase, release 2011_06.
0.05 respectively).
ith the same trend also in the MG132 treated L6ATM vs L6 comparison
Information..
Table 2 – Significant differentially regulated proteins in L6ATM MG132 and L6 MG132 treated cells identified by label-free
LC-MSE.
Accessiona Description (GN=gene name) Scoreb Highly
representedc
L6ATM
MG132: L6
MG132 ratiod
L6ATM MG132:
L6 MG132 Log(e)
ratio
L6ATM MG132:
L6 MG132 Log(e)
StdDev
Q9H853 Putative tubulin like protein alpha 4B
GN=TUBA4B
3538.69 L6ATM MG132
P01876 Ig alpha 1 chain C region GN=IGHA1 2023.93 L6ATM MG132
P60660 Myosin light polypeptide 6 GN=MYL6 1832.83 L6ATM MG132
P01903 HLA class II histocompatibility antigen
DR alpha chain GN=HLA DRA
1273.34 L6ATM MG132
P00441 Superoxide dismutase Cu Zn GN=SOD1 872.16 L6ATM MG132
Q15365 Poly rC binding protein 1 GN=PCBP1 395.32 L6ATM MG132
Q14240 Eukaryotic initiation factor 4A II
GN=EIF4A2
394.71 L6ATM MG132
P33316 Deoxyuridine 5 triphosphate
nucleotidohydrolase mitochondrial
GN=DUT
377.73 L6ATM MG132
P23284 Peptidyl prolyl cis trans isomerase B
GN=PPIB
347.71 L6ATM MG132
P52272 Heterogeneous nuclear
ribonucleoprotein M GN=HNRNPM
247.63 L6ATM MG132
P29692 Elongation factor 1 delta GN=EEF1D 206.91 L6ATM MG132
P11586 C 1 tetrahydrofolate synthase
cytoplasmic GN=MTHFD1
165.9 L6ATM MG132
P43243 Matrin 3 GN=MATR3 155.67 L6ATM MG132
A6NHL2 Tubulin alpha chain like 3 GN=TUBAL3 150.41 L6ATM MG132
Q16352 Alpha internexin GN=INA 150.09 L6ATM MG132
P17661 Desmin GN=DES 123.55 L6ATM MG132
Q08211 ATP dependent RNA helicase A
GN=DHX9
120.64 L6ATM MG132
P07197 Neurofilament medium polypeptide
GN=NEFM
114.22 L6ATM MG132
Q3ZCM7 Tubulin beta 8 chain GN=TUBB8 3060.88 4.48 1.5 0.24
P13797 Plastin 3 GN=PLS3 269.63 3.35 1.21 0.81
P09104 Gamma enolase GN=ENO2 1059.15 2.48 0.91 0.49
Q9H4B7 Tubulin beta 1 chain GN=TUBB1 724.79 2.34 0.85 0.19
P00558 Phosphoglycerate kinase 1 GN=PGK1 978.15 1.63 0.49 0.07
P30101 Protein disulfide isomerase A3
GN=PDIA3
420.89 1.43 0.36 0.05
P06744 Glucose 6 phosphate isomerase GN=GPI 231.58 1.39 0.33 0.09
Q00839 Heterogeneous nuclear
ribonucleoprotein U GN=HNRNPU
184.59 1.39 0.33 0.06
P14625 Endoplasmin GN=HSP90B1 599.41 0.72 −0.33 0.05
Q15084 Protein disulfide isomerase A6
GN=PDIA6
489.55 0.71 −0.34 0.07
Q01518 Adenylyl cyclase associated protein 1
GN=CAP1
256.75 0.71 −0.34 0.14
P08133 Annexin A6 GN=ANXA6 255.34 0.7 −0.35 0.18
P35579 Myosin 9 GN=MYH9 388.97 0.68 −0.39 0.05
Q562R1 Beta actin like protein 2 GN=ACTBL2 3295.43 0.68 −0.39 0.02
Q9UL46 Proteasome activator complex subunit 2
GN=PSME2
809.71 0.68 −0.38 0.08
P31946 14 3 3 protein beta alpha GN=YWHAB 12498.36 0.66 −0.41 0.09
Q07021 Complement component 1 Q subcom-
ponent binding protein mitochondrial
GN=C1QBP
343.71 0.64 −0.44 0.16
P31146 Coronin 1A GN=CORO1A 3535.44 0.63 −0.47 0.04
P08865 40 S ribosomal protein SA GN=RPSA 1296.7 0.55 −0.6 0.07
P34931 Heat shock 70 kDa protein 1 like
GN=HSPA1L
1371.37 0.55 −0.6 0.17
P20700 Lamin B1 GN=LMNB1 278.66 0.5 −0.7 0.12
Q58FG0 Putative heat shock protein HSP 90 alpha
A5 GN=HSP90AA5P
452.22 0.44 −0.83 0.04
Q9BYX7 Putative beta actin like protein 3
GN=POTEKP
1963.52 0.41 −0.9 0.09
(continued on next page)
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Table 2 (continued)
Accessiona Description (GN=gene name) Scoreb Highly
representedc
L6ATM
MG132: L6
MG132 ratiod
L6ATM MG132:
L6 MG132 Log(e)
ratio
L6ATM MG132:
L6 MG132 Log(e)
StdDev
P63104 14 3 3 protein zeta delta GN=YWHAZ 4893.36 0.41 −0.9 0.08
Q58FF7 Putative heat shock protein HSP 90 beta 3
GN=HSP90AB3P
1773.07 0.39 −0.95 0.17
Q9BUF5 Tubulin beta 6 chain GN=TUBB6 3586.51 0.36 −1.02 0.26
Q04917 14 3 3 protein eta GN=YWHAH 1239.37 0.36 −1.01 0.21
P07205 Phosphoglycerate kinase 2 GN=PGK2 286.5 0.24 −1.44 0.34
Q5TZA2 Rootletin GN=CROCC 48.78 L6 MG132
P42224 Signal transducer and activator of
transcription 1 alpha beta GN=STAT1
123.72 L6 MG132
P50990 T complex protein 1 subunit theta
GN=CCT8
126.06 L6 MG132
Q9P1U1 Actin related protein 3B GN=ACTR3B 136.44 L6 MG132
O15144 Actin related protein 2 3 complex
subunit 2 GN=ARPC2
139.01 L6 MG132
Q7KZF4 Staphylococcal nuclease domain
containing protein 1 GN=SND1
139.62 L6 MG132
Q15029 116 kDa U5 small nuclear
ribonucleoprotein component
GN=EFTUD2
146.71 L6 MG132
P29401 Transketolase GN=TKT 168.37 L6 MG132
O14556 Glyceraldehyde 3 phosphate
dehydrogenase testis specific
GN=GAPDHS
242.53 L6 MG132
P23381 Tryptophanyl tRNA synthetase
cytoplasmic GN=WARS
315.47 L6 MG132
P52815 39 S ribosomal protein L12
mitochondrial GN=MRPL12
334.73 L6 MG132
P52565 Rho GDP dissociation inhibitor 1
GN=ARHGDIA
403.89 L6 MG132
O75083 WD repeat containing protein 1
GN=WDR1
506.88 L6 MG132
Q99714 3 hydroxyacyl CoA dehydrogenase type 2
GN=HSD17B10
599.37 L6 MG132
Q9P1F3 Costars family protein C6orf115
GN=C6orf115
879.52 L6 MG132
P02042 Hemoglobin subunit delta GN=HBD 2211.94 L6 MG132
a: Unique protein sequence identifier according to UniProtKB/Swiss-Prot Protein Knowledgebase, release 2011_06.
b: ProteinLynx Global Server score.
c: Protein found highly represented in L6ATM MG132 or L6 MG132 treated cells (ratio >20 or <0.05 respectively).
d: Ratio of expression between L6ATM MG132 and L6 MG132.
Boldface type indicates proteins identified as differentially regulated and with the same trend also in the L6ATM vs L6 comparison.
Proteins levels assessed by way of western blotting are underlined.
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(SMA, a neurological disease) mouse model [44].
We analyzed by western blot other three proteins whose
levels were influenced by ATM expression andMG132 treatment:
STAT1, Lamin B1 and Matrin 3 (Table 2, Fig. 3E, F) to confirm the
regulation observed through proteomic analysis in both L6
treated cell lines. Signal Transducer and Activator of Transcrip-
tion 1 (STAT1) has been previously identified as a potential
substrate of ATM in nuclear extracts from irradiated (10 Gy) HeLa
cells [21] enforcing the idea that thismember of the STAT protein
family could be a direct target of ATM. In our study STAT1 is
down-regulated after proteasome blockage in L6 ATM compared
to L6, an evidence that could be eventually explained by
proteasome dependent degradation of STAT1 in ATM proficient
cells. In response to cytokines and growth factors, STAT family
members are phosphorylated by the receptor associated kinases,and then form dimers that translocate to the cell nucleus where
they act as transcription activators of a variety of genes, which is
thought to be important for cell viability in response to different
cell stimuli and pathogens [45]. There are some evidences in
literature which shine a light on the interplay between ATM and
STAT1 in the response to the DNA damage, that strengthen our
findings [46,47].
Moreover, we observed a decrease of Lamin B1(LMNB1) in L6
ATM treated cells; recently Barascu and colleagues demonstrated
an upregulation of Lamin B1 in A-T cells extract. The authors
stressed the point that LMNB1 overexpression is sufficient to
induce nuclear shape alterations and senescence in wild-type
cells. A-T patients suffer from premature ageing and this
observation led to the hypothesis that Lamin B1 dysregulation
could account for senescence in A-T cells [48]. The authors
related LMNB1 accumulation to A-T associated DDR defects,
Fig. 2 – PANTHER biological process classification. Pie chart of Gene Ontology distribution terms associated to differentially
regulated proteins.
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systematic analysis of human protein complexes to identify
chromosome segregation proteins, ATM and LMNB1were found
as bait-prey interactors from affinity-purification - mass spec-
trometry experiments (www.mitocheck.org) [49]; this experi-
mental evidence adds an interesting discussion point for the
possible direct interactionbetweenATMandLMNB1occurring in
the nuclear compartment while the highly ordered processes of
chromosome segregation and cell division is ongoing. Chromo-
some alignment,movement and segregation during cell division
involve interactions between the kinetochore and the mitotic
spindle through microtubule depolymerization/assembly [50].
Notably,we revealed differential expression of tubulins andHeat
Shock Proteins (HSPs) in both proteomics dataset. Although the
expression of some cytoskeleton proteins and HSPs could berelated to their abundance and therefore to their more easily
accessible identification by mass spectrometry experiments, in
our opinion the selective presence of centrosome components,
like tubulins, and Hsp 70 and 90 in our cell models is tied to their
function in cell cycle control, cell death and aggresome promot-
ing formation as described in several literature papers and
already observed in our previous work [51]. Mediators of stress
response (i.e., Checkpoint kinase 2 and its upstream regulator
ATM) indeed regulate centrosome inactivation checkpoint and
use stress inducted centrosome fragmentation or amplification
for eliminating damaged cells [52]. The role of HSPs in cell cycle
control and in signal transduction networks has been
indeed described and assigned both to Hsp 90 [53] and Hsp
70. In particular Hsp 70, as binding partners of hSNM1B/
Apollo, a protein with stimulating effect on ATM substrate
Table 3 – Ingenuity pathway analysis: top five canonical
pathway and molecular and cellular function.
L6ATM vs L6
Canonical pathways p-Value
Glycolysis/gluconeogenesis 3.34E−07
14-3-3-mediated signaling 1.51E−06
Cell cycle: G2/M DNA damage
checkpoint regulation
3.41E−04
p70S6K Signaling 5.18E−04
Myc mediated apoptosis signaling 8.10E−04
Molecular and cellular functions p-Value
Carbohydrate metabolism 7.11E−08 to 2.15E
−02
Cellular assembly and organization 9.45E−06 to 4.86E
−02
RNA post-transcriptional modification 2.42E−05 to 4.56E
−02
Drug metabolism 5.44E−05 to 2.76E
−02
Cell death 5.65E−05 to 4.81E
−02
L6ATM MG 132 vs L6 MG132
Canonical pathways p-Value
14-3-3-mediated signaling 6.05E−09
Glycolysis/gluconeogenesis 6.68E−07
Cell cycle: G2/M DNA damage checkpoint
regulation
4.77E−04
PI3K/AKT signaling 4.74E−04
p70S6K signaling 7.99E−04
Molecular and cellular functions p-Value
Cellular assembly and organization 3.3E−06 to 4.82E
−02
Cellular function and maintenance 3.3E−06 to 4.76E
−02
Carbohydrate metabolism 6.34E−06 to 4.43E
−02
Protein synthesis 7.7E−05 to 3.09E
−02
Cell morphology 1.18E−04 to 4.76E
−02
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rectly implicated in the maintenance of genome stability
[54]. Recent studies have also disclosed the involvement of
Hsp 70 in the preservation of cytoarchitecture. Zhang X. and
colleagues have indeed described the “unexpected role” of
Hsp 70 in promoting aggresome formation through the
interaction with the cochaperone ubiquitin ligase Carboxyl
terminal of Hsp70/Hsp90 interacting protein (CHIP) [55]. In
conclusion the participation of tubulins and HSPs in cell
surveillance mechanisms qualified them as additional
implementing checkpoints recruited and activated by
stress stimuli, thereby explaining in part their differentially
expressed levels in ATM absence in our proteomic
observations.
Among the proteins whose levels were influenced by ATM
expressionandMG132 treatment andwere analyzedbywestern
blot, Matrin 3 (MATR3) has already been identified as cross-
reacting protein to phospho-specific antibodies against known
ATM/ATR substrates [21]. Moreover, Matrin 3 has been alreadydescribed in literatureas involved in early stage of DSB response
[56]. In fact, treatment with the radiomimetic agent neocarzi-
nostatin andMATR3 depletion led to abnormal accumulation of
cells at the S-phase of the cell cycle. We observed an up-
regulatedprotein expression in L6ATM treated cells by nLC-MSE
approach. On the other hand, we could not confirm these data
through western blot analysis, thus we could not completely
rely on the proteomic evidence.
Therefore, as first conclusion we can argue that our experi-
mental data pointed out some stimulating proteins whose
expression changes depending on ATM in presence of protea-
some inhibition and could be considered potential ATM activity
substrate through the Ub–P system: the transcription activator
STAT1 and Lamin B1.
The second interesting point of discussion concerns the
significant overrepresentation of proteins involved in glycol-
ysis/gluconeogenesis pathway and carbohydrate metabolism
molecular function supporting the idea that there is an
evident switch of the metabolism, and in particular of the
carbohydrate process, in absence of the ATM expression. Our
observations showed how expression of ATM in L6 cells drives
higher expression of glycolytic enzymes (PGK1, PGAM1 and
PKM2), lower intermediate glycolytic metabolites and higher
pyruvate production probably by a stimulation of the cellular
rate of glycolysis. The higher lactate amounts may depend
consequently both on higher levels of its precursor (pyruvate)
and on its function as NADH depleting compound in order to
avoid the blockage of glycolysis due to the GAPDH enzymatic
step which is operated in near equilibrium condition. These
findings are related with the emerging role of ATM as central
regulator of cellular metabolism in response to oxidative
stress, linking genome stability, cell cycle and carbon catab-
olism [57–60]. ATM is largely nuclear, acting as modulator of
the cellular response to genotoxic stress and indeed our observed
up-regulationofhnRNPH inATMcells couldpossibly be related to
its function inmaintaining the genome integrity. In fact, hnRNPH
has been described as part of a rescue mechanism of p53 mRNA
3′-end processing regulation in DNA-damaged cells [61]. More-
over, there are increasing evidences that ATM deficiency is not
only cause of damage response lack of function; ATM localizes
predominantly in the cytoplasm in neuronal and neuron-like
cells [62,63] and cytoplasmatic ATM activity is involved in insulin
signaling pathways [30,32]). Cosentino et al. [33] demonstrated
the link between ATM and the pentose phosphate pathway (PPP)
by inducing Glucose-6-phosphate dehydrogenase (G6PD) activity.
G6PD is the limiting enzyme of the PPPmetabolic pathwaywhich
in turn is responsible for the production of the essential
antioxidant NADPH cofactor and nucleotide synthesis required
to promote DSB repair. Acting as a sensor of reactive oxygen
species (ROS), ATM could possibly shift the carbohydrate
metabolism from glycolysis to the oxidative PPP under stress
condition like DSBs. Shifting the energy source glucose-6–
phosphate from glycolysis to PPP, the energy stored in carbohy-
drate backbones molecules will be shifted toward NADPH
production and nucleotide synthesis instead of ATP and NADH
produced by glycolysis. In our studywe hypothesize a shift of the
glycolytic pathway itself in ATM activity absence which may be
due to an impairment in the functional link between glycolysis
and mitochondrial metabolism. In a recent published paper [36],
Mongiardi et al. demonstrated that ATM defective cells have an
Fig. 3 – Immunoblotting validation of shotgun proteomic analysis. (A) Proteins levels revealed with specific antibodies in
cellular extracts from L6 and L6ATM cells and a different human A-T lymphoblastoid (GM-03189) cell line characterized by
distinct genetic background. Representative blots from three independent experiments with similar results are shown.
Controls of equal protein loading were confirmed by α-Tubulin expression (mAb recognizing different isoforms other than
ones identified by proteomic analysis). (B) Density of specific bands was measured by the image analysis software:
ImageQuant TL; the level of each protein detected in A, has been normalized on the corresponding amount of α-Tubulin. The
results are shown as themean of the three independent experiments, and error bars represent standard deviation. (C) Proteins
expression levels were analyzed also in HeLa cells interfered (shATM) or not (scramble, shSc) for ATM expression.
Representative blots from three independent experiments with similar results are shown. (D) The level of each protein has
been quantified and normalized as in B. The results are shown as the mean of the three independent experiments as in B.
(E) Proteins levels detected in L6 and L6ATM cells after proteasome blockage. (F) The level of each protein has been quantified
and normalized as in B. The results are shown as the mean of the three independent experiments as in B.
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in terms of HIF-1α stabilization and transcription of Hypoxia-
responsive genes, including PGK1 and MIF. Accordingly, we
identified these two gene products as down-regulated in L6 cells
respect to L6ATM. The proposed explanation relays on a blunted
response to hypoxia and intracellular concentration of ROS in
response to hypoxia which in turn is due to an impaired sensing
of oxygen variation. On the other end, in our study, the observed
up-regulation of GLRX1 in ATM deficient cells could possibly be
related to an adaptive response tomitigate the challenge of redox
unbalance in ATM absence, a continuous stress state leading to
genomic instability, accumulation of unrepaired DNA, constant
activation of the DNA repair mechanisms and impaired mito-
chondrial activity. The transcription factor NF- κB, which has a
pivotal role in cell survival and proliferation, is subject to
regulation by redox changes; this regulation relies in part on theoxidative inactivation by means of S-glutathionylation of the
Inhibitory κB kinase (IKK) β-subunit of the IKK signalosome;
overexpression of GLRX1 catalyzes deglutathionylation of IKKβ
and enhances NF-κB activation [64]. This evidence, our obser-
vation of GLRX1 up-regulation in ATM absence and the ATM
dependentNEMOubiquitylation andNF-κB activation [19] could
possibly open anew route to an interestingvisionon the linkage
between ATM, NF-κB, genotoxic and oxidative stress, and
cellular metabolism.
The present study provides initial evidences toward a new
scenario of ATM function in cellular homeostasis; we are
aware of the necessity to go deep inside this issue to complete
the schema of signaling pathways beyond the differences in
the metabolism response correlated to the loss of function of
ATM. Nevertheless, all the described evidences begin to explain
the intricate scenario beyond the A-T syndromewhich could be
Fig. 4 – Metabolomics analysis. Metabolites were extracted
from L6 and L6ATM cells in presence and absence of MG132.
Levels of glucose 6–phosphate (G 6–P), fructose
1,6–bisphosphate (F 1,6–P), glyceraldehyde 3–phosphate
(G 3–P), pyruvate (P) and lactate (L) in each extract were
determined by mass spectrometry and reported as relative
response (arbitrary units, calculated as the peak area of each
analyte normalized to the total chromatographic peak areas).
Error bars represent standard deviation calculated on three
different analytical runs.
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response lack of function.5. Conclusions
This research has led to the identification of a set of proteins
whose levels and stability is modulated through ATM, therefore
contributing to give insight into the molecular events of ATM
deficiency relevant for neurodegeneration and immunodeficien-
cy linked toA-T. Pattern of differentially expressedproteins in the
presence and in the absence of ATM were obtained by shotgun
label-freemass spectrometry characterization of lymphoblastoid
ATM deficient and proficient cells. The treatment with MG132
highlights those proteinswhose expression ismodulated byATM
most likely through theubiquitin–proteasomesystemandwhose
half-life is particularly short and their ATM dependent
modulation levels over the whole proteome would be partially
masked in a direct investigation. Our study pointed out some
stimulating proteins whose expression changes could possibly
depend on the ATM presence and the blockage of proteasome
activity: Pyruvate kinase isozymes M1 M2, a glycolytic enzyme;Plastin 3, already known as involved neurological disease;
the transcription activator STAT1 and Lamin B1. Moreover,
proteomic andmetabolomics data evidenceamodulation of the
carbohydrate metabolism in absence of ATM activity, in
particular a different glycolysis rate. Our findings are related
with the emerging role of ATM as central regulator of cellular
carbohydrate metabolism in response to oxidative stress.
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